Hormone clue may unmask kidney danger in diabetes
NCT ID NCT06190158
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This study investigates whether people with type 2 diabetes who have or are at risk for chronic kidney disease produce too much aldosterone, a hormone that regulates salt and blood pressure. Participants undergo several suppression tests—including oral sodium, saline infusion, and medication challenges—to measure how much aldosterone their bodies produce independently of normal triggers. The goal is to understand if this hidden hormone excess is linked to kidney damage, which could lead to better detection and treatment strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Diagnostic tests including oral sodium, saline, captopril, dexamethasone, and cosyntropin to assess aldosterone production
- What this could lead to
- If this works, it could identify a treatable hormone imbalance that contributes to kidney disease in people with type 2 diabetes, potentially guiding earlier interventions.
- What could go wrong
- This is an early-phase diagnostic study, so it won't directly test treatments. The tests may not reliably distinguish the condition, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Can a new graft keep dialysis access working longer?
- Can a common gout pill shield hearts in kidney disease?
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Can a single pill tackle both fatty liver and diabetes?